GlassScriptPhysician profile
Zainub Abdullah
NPI 1669156386
$1,301.04
in general payments reported to CMS, 2019-2025
12 companies · $974 in 2025
The $974 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $299 · 2024: $28.00 · 2025: $974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,301.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $249.39 | 2023 | Tepezza, Uplizna |
| Sun Pharmaceutical Industries INC. | $174.56 | 2025 | |
| Dompe US, INC. | $149.22 | 2025 | Oxervate |
| Alexion Pharmaceuticals, INC. | $139.53 | 2025 | Ultomiris |
| Sight Sciences, INC. | $131.73 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Amgen INC. | $124.31 | 2025 | Uplizna |
| Carl Zeiss Meditec USA, INC. | $123.76 | 2025 | Cirrus Hd-Oct |
| Tarsus Pharmaceuticals, INC. | $104.87 | 2025 | |
| Glaukos Corporation | $28.00 | 2024 | Idose |
| Novartis Pharmaceuticals Corporation | $26.03 | 2023 | |
| Alcon Vision LLC | $25.82 | 2025 | Clareon |
| Aurinia Pharma U.S., INC. | $23.82 | 2023 | Lupkynis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zainub Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.